Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Lam Research
LRCX
|
$792M |
| 2 |
Johnson & Johnson
JNJ
|
$659M |
| 3 |
Datadog
DDOG
|
$571M |
| 4 |
Amazon
AMZN
|
$474M |
| 5 |
Broadcom
AVGO
|
$458M |
Top Sells
| 1 |
Workday
WDAY
|
$1.23B |
| 2 |
AbbVie
ABBV
|
$1.03B |
| 3 |
Advanced Micro Devices
AMD
|
$686M |
| 4 |
Honeywell
HON
|
$673M |
| 5 |
Amgen
AMGN
|
$620M |
Sector Composition
| 1 | Technology | 34.72% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Rhythm Pharmaceuticals
RYTM
$6.78B
| $68.3M | 0.03% |
1,219,554
+621,432
| +104% | +$34.8M |
|
327
Walmart
WMT
$801B
| $68M | 0.03% |
752,624
+111,513
| +17% | +$10.1M |
|
328
Federal Realty Investment Trust
FRT
$8.86B
| $66.7M | 0.03% |
595,416
-15,670
| -3% | -$1.75M |
|
329
Constellium
CSTM
$2.04B
| $66.2M | 0.03% |
6,445,290
+292,335
| +5% | +$3M |
|
|
EXE
330
Expand Energy Corporation Common Stock
EXE
$22.7B
| $65.9M | 0.03% |
662,381
+48,279
| +8% | +$4.81M |
|
331
Weatherford International
WFRD
$4.49B
| $65M | 0.03% |
907,593
+393,955
| +77% | +$28.2M |
|
332
EastGroup Properties
EGP
$8.97B
| $63.7M | 0.03% |
396,434
+8,462
| +2% | +$1.36M |
|
333
Alcon
ALC
$39.6B
| $63.4M | 0.03% |
747,664
-88,535
| -11% | -$7.51M |
|
334
Colliers International
CIGI
$8.43B
| $63.4M | 0.03% |
466,425
+5,850
| +1% | +$795K |
|
335
Impinj
PI
$5.56B
| $63.3M | 0.03% |
435,960
+424,851
| +3,824% | +$61.7M |
|
336
UDR
UDR
$13B
| $62.3M | 0.03% |
1,435,540
-109,256
| -7% | -$4.74M |
|
337
HDFC Bank
HDB
$361B
| $62.2M | 0.03% |
973,979
-2,794
| -0.3% | -$178K |
|
338
Ciena
CIEN
$16.5B
| $61.9M | 0.03% |
729,722
+661,630
| +972% | +$56.1M |
|
339
NRG Energy
NRG
$28.6B
| $61.8M | 0.03% |
685,359
+16,383
| +2% | +$1.48M |
|
340
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
| $61.4M | 0.03% |
1,393,587
-33,907
| -2% | -$1.49M |
|
341
Clarivate
CLVT
$2.96B
| $60.9M | 0.03% |
11,978,592
-587,147
| -5% | -$2.98M |
|
342
Sabra Healthcare REIT
SBRA
$4.56B
| $60.7M | 0.03% |
3,504,809
+657,950
| +23% | +$11.4M |
|
343
Williams-Sonoma
WSM
$24.7B
| $60.6M | 0.03% |
327,421
+5,172
| +2% | +$958K |
|
344
Snowflake
SNOW
$75.3B
| $60.2M | 0.03% |
389,756
+364,525
| +1,445% | +$56.3M |
|
345
Vanguard Small-Cap ETF
VB
$67.2B
| $60.1M | 0.03% |
250,094
-106,980
| -30% | -$25.7M |
|
346
Kinsale Capital Group
KNSL
$10.6B
| $59.9M | 0.03% |
128,830
+36,978
| +40% | +$17.2M |
|
|
MREO
347
Mereo BioPharma
MREO
$282M
| $59.8M | 0.03% |
17,122,563
+4,776,697
| +39% | +$16.7M |
|
348
UBS Group
UBS
$128B
| $59.7M | 0.03% |
1,951,232
-115,617
| -6% | -$3.54M |
|
349
Roper Technologies
ROP
$55.8B
| $59.2M | 0.03% |
113,879
-2,065
| -2% | -$1.07M |
|
350
Kirby Corp
KEX
$4.97B
| $58.6M | 0.03% |
554,190
+2,550
| +0.5% | +$270K |
|